U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06904807) titled 'A Phase I Study to Evaluate LIFE-001' on March 14.
Brief Summary: The goal of this clinical trial is to learn if LIFE-001 is safe and tolerable for healthy adult volunteers.
Study Start Date: April 11
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: LIFE-001
Single dose of LIFE-001 between 10mg and 300mg administered subcutaneously
DRUG: Placebo
Single dose of placebo comparator administered subcutaneously
DRUG: LIFE-001
Four doses of LIFE-001 between 50mg and 300mg administered subcutaneously seven days apart
DRUG: Placebo
Four doses of placebo comparator administered subcutaneously seven da...